Carlos Penha-Gonçalves
Raffaella Gozzelino
Luciana V. de Moraes- Instituto Gulbenkian de Ciência, Oeiras, Portugal
Plasmodium infection during gestation may lead to severe clinical manifestations including abortion, stillbirth, intrauterine growth retardation, and low birth weight. Mechanisms underlying such poor pregnancy outcomes are still unclear. In the animal model of severe placental malaria (PM), in utero fetal death frequently occurs and mothers often succumb to infection before or immediately after delivery. Plasmodium berghei-infected erythrocytes (IEs) continuously accumulate in the placenta, where they are then phagocytosed by fetal-derived placental cells, namely trophoblasts. Inside the phagosomes, disruption of IEs leads to the release of non-hemoglobin bound heme, which is subsequently catabolized by heme oxygenase-1 into carbon monoxide, biliverdin, and labile iron. Fine-tuned regulatory mechanisms operate to maintain iron homeostasis, preventing the deleterious effect of iron-induced oxidative stress. Our preliminary results demonstrate that iron overload in trophoblasts of P. berghei-infected placenta is associated with fetal death. Placentas which supported normally developing embryos showed no iron accumulation within the trophoblasts. Placentas from dead fetuses showed massive iron accumulation, which was associated with parasitic burden. Here we present preliminary data suggesting that disruption of iron homeostasis in trophoblasts during the course of PM is a consequence of heme accumulation after intense IE engulfment. We propose that iron overload in placenta is a pathogenic component of PM, contributing to fetal death. The mechanism through which it operates still needs to be elucidated.
Introduction
Malaria is an infectious disease that affects millions of individuals every year and remains one of the major causes of morbidity and mortality worldwide (WHO | World Malaria Report, 2013). The disease is transmitted by Anopheles mosquito carrying Plasmodium parasites. Once injected in the blood stream, Plasmodium replicate and mature in the liver (liver stage) before infecting erythrocytes (blood stage; Schofield and Grau, 2005). The blood stage of infection is known to be associated to clinical manifestations of the disease (Mackintosh et al., 2004; Haldar et al., 2007). Plasmodium parasites proliferate inside red blood cells; within these erythrocytes circulate freely in the bloodstream and are under risk of removal by the spleen – the organ responsible for eliminating old and modified erythrocytes (Janicik et al., 1978). To avoid this host defense mechanism, intracellular parasites export to the erythrocyte membrane molecules that interact with receptors on the vascular endothelium (Krücken et al., 2005), enabling adherence/sequestration of the infected erythrocyte (IE) in the microvasculature of specific organs such as lung, heart, and brain (Pongponratn et al., 1991). IE sequestration is considered one of the major factors in triggering organ inflammation, leading to severe clinical forms of disease such as cerebral malaria (Carter et al., 2005; Ponsford et al., 2012). It has recently been shown that proliferation and maturation of mutant parasites lacking ability to adhere to host endothelium is reduced in mice when compared to wild-type parasites (Fonager et al., 2012) strengthening the hypothesis that adherence impacts Plasmodium proliferation during the blood stage of infection.
In 2007 over 125 million women living in areas with Plasmodium falciparum and or P. vivax transmission became pregnant and at risk of developing malaria (Dellicour et al., 2010). Pregnant women bitten by infected mosquitoes can develop placental malaria (PM; known also as pregnancy malaria) – a disease characterized by adverse pregnancy outcomes such as abortion, stillbirth, premature delivery and low birth weight babies, which in turn increases infant morbidity. These clinical features can be recapitulated in a BALB/c mouse model of infection at mid-stage pregnancy (Neres et al., 2008) and are associated to accumulation of Plasmodium IEs in the placenta (Fried and Duffy, 1996).
The placenta is a favored niche for IE sequestration and there are two different explanations for this phenomenon. Placental cells, specifically trophoblasts which are epithelial cells of fetal origin, express chondroitin sulfate A (CSA) – a sulfated glycosaminoglycan – on their surface (Duffy and Fried, 1999). This offers a binding site for VAR2CSA, a protein encoded for the human malaria parasite P. falciparum, exposed on the membrane of IEs (Salanti et al., 2003, 2004; Duffy et al., 2006; Srivastava et al., 2010). Physical CSA–VAR2CSA interaction allows the adhesion of IEs to placental tissue. Microcirculatory dynamics of the placenta is another important factor in IE sequestration. We recently described that the speed of maternal blood circulation in the mouse placenta is heterogeneous: there are areas of high, moderate, and low blood flow (de Moraes et al., 2013). In placentas infected with P. berghei – a rodent parasite that lacks the VAR2CSA molecule (Jemmely et al., 2010) – accumulation of IEs is increased in low maternal blood flow regions (de Moraes et al., 2013). This highlights the relevance of placental tissue configuration in promoting sequestration of Plasmodium IEs. We hypothesized that IE sequestration may occur through specific interaction of IEs with the trophoblast membrane and is favored by IE arrest in maternal regions characterized of low blood flow.
Placental IE sequestration leads to a local inflammatory response characterized by monocyte infiltration (Abrams et al., 2003). Trophoblasts are also capable of phagocytosing IEs (de Moraes et al., 2013) yeast and bacteria (Amarante-Paffaro et al., 2004) in an attempt to eliminate invading microbes. Trophoblast responses to infection may be deleterious to the developing fetus. Despite many evidences that link PM to placental inflammation, mechanisms underlying poor pregnancy outcomes are still unclear.
Our preliminary data in a mouse model of PM show an association between iron overload in trophoblast of P. berghei-infected placentas and fetal death. Iron accumulation was observed in 43% of placentas from dead fetuses and was associated to the dose of injected IEs. Iron deposits were never detected in placentas from live embryos. Our preliminary results also show downregulation of mRNA expression of the heme exporter feline leukemia virus C receptor 1a (FLVCR1a) in infected placentas suggesting a role for this molecule in dysregulation of iron homeostasis in PM. Here, we discuss how iron is regulated during pregnancy and develop a hypothesis to explain infection-induced iron overload in trophoblasts. This may help explain the poor pregnancy outcomes brought about by Plasmodium infections during gestation.
Iron and Pregnancy
Maternal Iron Homeostasis
Iron is essential for all living organisms. It is important in a variety of biological functions involving reduction and oxidation reactions which are crucial for cell survival and proliferation (Crichton and Charloteaux-Wauters, 1987). Iron can exchange electrons with a number of different substrates, necessitating tight control of the reactivity of this metal (Hentze et al., 2004). Control is provided by cellular and systemic mechanisms that have been evolved to maintain iron homeostasis and prevent its participation in the Fenton chemistry (Fenton, 1894). Disruption of iron homeostasis leads to production of highly reactive hydroxyl radicals, the cytotoxic effect of which is associated with tissue iron overload, organ dysfunction and disease severity, recently demonstrated in the case of severe forms of malaria (Gozzelino et al., 2012).
Dietary iron is absorbed by the duodenum, transported into the cytosol by the divalent metal transporter-1 (DMT1; Fleming et al., 1997; Gunshin et al., 1997; Veuthy and Wessling-Resnick, 2014) and then either stored within multimeric subunits of ferritin (Harrison and Arosio, 1996) or released into the circulation by the iron exporter ferroportin (Donovan et al., 2000; McKie et al., 2000). Extracellular iron is bound to transferrin (Tf) and delivered to cells by interaction with Tf receptors (TfR; Aisen, 1998) where it is mainly used for heme biosynthesis and erythropoiesis (Andrews, 2000).
During pregnancy, maternal iron absorbance increases substantially throughout the gestational period [from 0.8 mg/day in the first trimester to 7.5 mg/day in the third trimester (Bothwell, 2000)] to fulfill the needs of the developing fetus. Increased iron absorption is also required for maternal erythropoiesis, to maintain hemoglobin (Hb) levels (Bothwell, 2000) and to increase the iron stores to compensate for blood loss during delivery (Milman, 2006). Studies have shown that 40–70% of iron that is transferred to the fetus derives from maternal iron stores (Murray and Stein, 1970; Bothwell, 2000), suggesting that fetus can mobilize iron from this resource; this will be further discussed.
Maternal iron status during pregnancy can be monitored by biomarkers such as Hb, hematocrit, serum ferritin (SF), serum soluble TfR (sTfR), and total body iron (TBI). SF concentration is a well established marker for iron reserves; SF levels ≤30 μg/L are indicative of low iron reserves and levels ≤12 μg/L are associated with iron deficiency (Milman, 2006). Soluble TfR are detached receptors from young erythrocytes which in high concentrations indicate iron deficiency at cellular level and may be useful marker to monitor erythropoiesis (Feelders et al., 1999). Both SF and sTfR measurements during pregnancy yield reliable information on maternal iron status; the sTfR-index (sTfR/log SF) is a practicable parameter for patients with depleted iron stores (Punnonen et al., 1997) and during pregnancy may correct for plasma volume expansion differences (Cao and O’Brien, 2013).
Another parameter for assessment of iron homeostasis is hepcidin, a hormone mainly produced by the liver that controls iron efflux. Hepcidin binds to ferroportin, induces internalization and degradation of this molecule, preventing iron export from the cell (Nemeth et al., 2004). Levels of hepcidin vary according to the iron concentrations in circulation, and kinetics of this hormone during pregnancy is indicative of the status of maternal iron stores (Simavli et al., 2014). In a cohort of healthy Northern European pregnant women, reduced levels of hepcidin correlated with decreased ferritin and iron concentrations, which occur simultaneously to an increase in sTfR-index in the third trimester (van Santen et al., 2013). As proposed in this study, low hepcidin production might reflect increased iron demands of the developing fetus and increase in maternal erythropoietic activity during pregnancy, which reduces maternal iron stores.
The effect of Plasmodium placental infection on maternal and cord blood iron parameters [hepcidin, iron, ferritin, sTfR, Tf saturation (TS)] has been considered. In a population from Gabon, anemic women with PM had a trend for lower levels of sTfR compared to anemic women without PM suggesting that parasitemia could affect proliferation of erythroid progenitors (Van Santen et al., 2011). A slight but not significant increase in ferritin concentrations was also observed in these anemic and infected pregnant women. Studies conducted in Malawi showed that infected pregnant women exhibited increased levels of ferritin compared to non-infected and that cord blood ferritin was correlated with increased maternal parasitemia and lower birth weight (Abrams et al., 2005). Moreover Hb levels in the fetus were not affected by infection suggesting that fetal iron stores are preserved. Other studies corroborate these observations showing that neither maternal or placental infection had an effect on Hb levels (Mokuolu et al., 2009; Van Santen et al., 2011) as well on iron parameters in the cord blood (Van Santen et al., 2011).
Iron Transport From Mother to Fetus
Both in mouse and human placentas, maternal blood is directly in contact with trophoblasts. These cells, more specifically named cytotrophoblast and syncythiotrophoblasts, are arranged in layers to form a barrier separating maternal from fetal blood and allow flux of gas and nutrient to the fetus through different mechanisms (Sibley et al., 2010; Figure 1A). Iron is transferred across the placenta via proteins involved in iron transfer; the detailed mechanisms regulating trophoblasts uptake of iron from maternal circulation and transfer to the fetus are still unclear. It has been suggested that iron uptake from maternal serum may occur primarily via DMT1 (Gruper et al., 2005). DMT1 is a transmembrane glycoprotein that transports divalent iron into the cytoplasm; it is located both in the cell membrane and on late endosomes (Andrews, 1999). Expression of DMT1 on the apical side of human trophoblasts (facing maternal blood) suggests DMT1 could play a major role in iron uptake by trophoblasts also during pregnancy (Gruper et al., 2005). In human term placentas, DMT1 is located predominantly on the maternal side of syncytiotrophoblasts, more rarely on the fetal side (Li et al., 2012b). Fetal iron uptake is also mediated by the expression of TfR on the apical membrane of human placenta (Kroos et al., 1996; Georgieff et al., 2000; Bastin et al., 2006). This suggests that the mechanism also operates to ensure iron transport from maternal circulation to the fetus. TfR is induced during pregnancy, in response to iron deficiency; it is rapidly transcytosed to the apical membrane of syncytiotrophoblasts (Gruper et al., 2005), as demonstrated in rodent (Gambling et al., 2001; Cornock et al., 2013) and human studies (Li et al., 2012a) of maternal iron deficiency.
FIGURE 1. Phagocytosis by trophoblasts of infected mouse placentas at end-stage gestation. (A) placental histology showing trophoblasts [cytotrophoblasts (CTB) and syncythiotrophoblasts (STB)], maternal blood space (MBS), endothelial cell (EC), and fetal capillary (FC) corresponding to the scheme on the upper right-hand panel. (B,C) placental sections showing engulfed IEs (arrows in B,C) in trophoblasts. Arrowheads point to IEs. Scale bar 25 μm.
Mechanisms of iron transfer from mother to fetus must be well orchestrated to guarantee adequate iron supply to the developing embryo. The cross-talk between mother, placenta (trophoblast) and fetus is not yet well understood but the conductor of the symphony seems to be the fetus. Studies have shown that fetal liver iron status directly correlates with TfR expression on placenta and maternal liver, suggesting that the embryo regulates iron uptake by the mother and at the trophoblast level (Gambling et al., 2009). In a rat model of dietary iron deficiency using two different strains, placental TfR and DMT1 expression were upregulated, possibly to increase iron transport and supply to the fetus (Cornock et al., 2013). These studies also showed inter-strain differences in maternal liver iron contents in controls not associated to expression of duodenal iron transporters but rather placental efficiency in iron uptake and transfer to the embryo. In the placenta TfR seems to be modulated by hepcidin; studies on hepcidin transgenic embryos have shown that expression of TfR mRNA was significantly downregulated in the placentas, suggesting that hepcidin is constitutively produced by the fetal liver and possibly controlled by fetal iron contents (Gambling et al., 2009) modulating the iron uptake by trophoblast (Martin et al., 2004). Underlying mechanisms are still unclear. Taken together these data strongly suggest that fetal iron status regulates trophoblast iron uptake.
Much evidence supports ferroportin 1 (FPN1) as the major iron export molecule due to its high expression on the basal membrane of the syncytiotrophoblast (Donovan et al., 2000; McKie et al., 2000; Bastin et al., 2006). However, the observation that FPN mRNA expression (Gambling et al., 2001; Li et al., 2008) and protein levels (Gambling et al., 2009; Cornock et al., 2013) on trophoblasts of rat placentas were not altered regardless of maternal iron status suggests that regulation of iron efflux from trophoblast may not involve the FPN-hepcidin pathway (Gambling et al., 2009; Cornock et al., 2013). The observation that DMT1 is also localized on the syncytiotrophoblast basal membrane raises the possibility that this molecule could be involved in iron efflux to the fetal serum (Georgieff et al., 2000).
Iron Deficiency and Pregnancy Malaria
In malaria endemic regions, pregnant women with nutritional iron deficiency who are infected with Plasmodium may be protected from PM (Kabyemela et al., 2008) but are at risk of developing severe anemia (Guidotti, 2000) increasing the risk of perinatal mortality and morbidity (Levy et al., 2005). The apparent contradiction stems from two distinct effects of iron: low levels may impair fetal development; high concentration could promote parasite replication, as this metal is strictly required for the viability of these pathogens (Cabantchik et al., 1996; Ganz, 2009). Iron supplementation trials have shown contradictory results on pregnancy outcomes during malaria infection (Nacher et al., 2003; Friedman et al., 2009). Iron and acid folic supplementation has been recommended for all women of child-bearing age in malaria endemic regions with the aim of overcoming iron deficiency. Safety of this strategy in terms of malaria risk has not been assessed and remains a concern. Increased malaria risk has been observed in pregnant women who receive intravenous iron (Oppenheimer et al., 1986) but oral iron supplementation increased neither the prevalence nor severity of malaria in Gambian women (Menendez et al., 1994). In contrast, iron deficiency has been associated with decreased susceptibility to P. falciparum infection in pregnant women in Tanzania (Kabyemela et al., 2008) but PM appeared to protect Malawian pregnant women from maternal iron deficiency (Senga et al., 2011). Likewise Sudanese women with P. falciparum PM had low frequency of anemia (Adam et al., 2012). These epidemiological findings suggest impairment of iron metabolism over the course of malaria infection during pregnancy. On the one hand, decreased iron availability appears to protect against PM, probably by depriving the parasite of iron required for expansion during blood stage infection. On the other hand, PM appears to protect pregnant women from developing iron deficiency, possibly by impairing the mechanism of iron transport in the placenta. Dysregulation of iron metabolism and distribution in malaria infection may be exacerbated during pregnancy, due to increased maternal erythropoiesis and fetal needs. There is little information on whether alterations in the intricate interaction between maternal and fetal iron metabolism in PM impose restrictions on fetal growth and survival. There are so far no hypotheses to explain the interplay between iron homoeostasis, pregnancy status, and malaria infection.
Iron Dysregulation in the PM Model
Trophoblast Response to Infection
A critical factor in PM pathogenesis is sequestration of IEs in the placenta. This process may occur through interaction of VAR2CSA exposed on IE membrane with CSA expressed on trophoblasts (Fried and Duffy, 1996) or by arrest of IEs in maternal low blood flow areas (de Moraes et al., 2013). In P. falciparum infection, VAR2CSA is so far the best characterized molecule involved in cytoadherence (Salanti et al., 2003, 2004) and a favored target of PM vaccines (Kane and Taylor-Robinson, 2011). Trophoblasts can respond to infection after IE binding. In vitro studies with P. falciparum have shown that following IE-trophoblast interaction placental cells produce chemokines such as macrophage inflammatory protein-1 alpha (MIP-1α/CCL3) and macrophage migration inhibitory factor (MIF) via activation of c-Jun N-terminal kinase I (JNK I) which in turn recruit peripheral blood mononuclear cells to the site (Lucchi et al., 2008); this inflammatory milieu contributes to PM pathology (Figure 2). Trophoblasts have also been shown to respond to Plasmodium products such as hemozoin (crystallized heme from Hb digestion during the blood stage of Plasmodium infection; Lucchi et al., 2011), P. chabaudi IEs (Poovassery and Moore, 2009), and pathogenic bacteria (Griesinger et al., 2001) releasing pro-inflammatory factors.
FIGURE 2. Trophoblast response to IE binding. (A) Cytoadhesion of IE to trophoblast (TB) via VAR2CSA-CSA interaction leads to chemokine production by these activated cells (B) and recruitment of inflammatory cells to the site (C). Sequence of events compiled based on studies from (Fried and Duffy, 1996; Salanti et al., 2004; Lucchi et al., 2008; Srivastava et al., 2010).
Despite VAR2CSA-CSA interactions being exclusive to P. falciparum-induced PM, the observation that other Plasmodium parasites are capable of causing malaria during pregnancy both in humans (Poespoprodjo et al., 2008) and mice (Neres et al., 2008; Rodrigues-Duarte et al., 2012) suggests involvement of other parasite molecules that could target CSA. This is supported by in vitro data showing that P. berghei IE binding is CSA-dependent (Neres et al., 2008). The contribution of VAR2CSA and non-VAR2CSA molecules to PM is currently being addressed by the characterization of a PM mouse model induced by transgenic P. berghei parasite that expresses VAR2CSA molecule (de Moraes et al., unpublished data). Our recent study of blood circulation patterns in mouse placenta using intra-vital microscopy showed that IEs and non-IEs are arrested in regions where maternal circulation is stationary (de Moraes et al., 2013) suggesting that here P. berghei IE sequestration might be independent of molecular interactions with trophoblasts.
Stationary IEs in low maternal blood spaces can be engulfed by trophoblasts. Phagocytic activity of trophoblasts occurs in early stages of pregnancy, during implantation of blastocyst (Tachi et al., 1970; Bevilacqua and Abrahamsohn, 1989); engulfment of maternal components such as endometrial cells, red blood cells, and epithelial cells creates space for embryo attachment to the endometrium and its nutrition (Bevilacqua and Abrahamsohn, 1989). After maturation, trophoblasts seem to retain their phagocytic activity. Studies have shown that trophoblasts from mid-stage gestation are capable of phagocytosing erythrocytes (Albieri and Bevilacqua, 1996), P. chabaudi IEs (Poovassery and Moore, 2009), P. berghei parasitic material in vitro (Pavia and Niederbuhl, 1991) as well as yeast and bacteria in vivo (Amarante-Paffaro et al., 2004). Our recent observation using intra-vital microscopy show that in placentas from gestational day 18, P. berghei IEs are engulfed by trophoblasts supporting the idea that phagocytic function is extended until termination of pregnancy (de Moraes et al., 2013; Figures 1B,C).
Disruption of Intracellular Heme Homeostasis as a Mechanism Involved in Excessive Iron Accumulation in Trophoblast
In our PM model, abortions, stillbirths, underweight babies, and maternal mortality are consequences of Plasmodium infection during pregnancy. These features are associated with irreversible placental damage, due to IE accumulation. Here we present a novel hypothesis as to the mechanisms underlying fetal death in PM. Fetal death/loss during mid-gestation (abortions) has already been shown to be associated to pro-inflammatory cytokine response to Plasmodium infection in the mouse (Poovassery and Moore, 2009; Poovassery et al., 2009) and in humans (Okoko et al., 2003), and to microcirculatory impairments (Avery et al., 2012). In our model fetal death was observed at end-stage gestation (G19/20): 8/30 fetuses were expelled at G19 and were very small for gestational age. The remaining fetuses were assessed in utero, were in general fully developed but underweight. Our preliminary data show iron accumulation in trophoblasts in 43% of the infected placentas from dead fetuses (Table 1), which was associated to the dose/number of Plasmodium-IEs used in infection of pregnant mice (Figure 3 and Table 2).
TABLE 1. Iron accumulation in placentas from live and dead fetuses.
FIGURE 3. Iron accumulation in placenta is dependent on dose of infection. Pregnant mice were infected with either 104 or 106 Plasmodium berghei-infected erythrocytes (IEs). Placentas from Plasmodium-infected pregnant mice were collected at G19/20 and processed for iron measurements as previously described (Gozzelino et al., 2012). Briefly placentas were dehydrated overnight, dissolved in 3 M HCl/trichloroacetic acid (TCA) 10% for 24 h. Labile iron was detected by colorimetric reagent (bathophenanthroline-disulfonic acid; BPTS) and absorbance was measured by spectrophotometer (SmartSpec 3000, Bio-Rad); **p < 0.01.
TABLE 2. Iron accumulation in placentas from dead fetuses according to IE dose.
Iron deposits were assessed in placental sections by Perl’s Prussian blue staining (Figure 4). The pattern of excessive iron staining in placentas from dead fetuses (Figures 4E,F) was observed neither in non-infected (Figures 4A,B) nor in infected placentas from live but underweight fetuses (Figures 4C,D); this strongly suggests that iron overload in trophoblasts is associated with the most severe pathological events. Iron was accumulated inside trophoblasts (Figures 4E,F) and, in particular, at the interface between trophoblasts and fetal blood capillary and, possibly in fetal circulation (Figure 4F). Although further experiments would be required to validate the latter observation, staining was not observed in maternal blood spaces (Figures 4E–G) supporting the specificity of the results obtained. We also observed loss of placental tissue integrity and cellular damage in regions of iron positive staining (Figure 4E), which suggests that iron overload in trophoblasts might induce programmed cell death, presumably mediated by oxidative stress. Increased apoptosis of trophoblasts has been linked to adverse pregnancy outcomes such as low birth weight due to intrauterine growth retardation (IUGR; Endo et al., 2005), spontaneous abortion (Olivares et al., 2002; Nakashima et al., 2008), and in a mouse model of intrauterine fetal death (Mu et al., 2003). In an experimental model of iron overload during pregnancy, iron accumulation in trophoblasts showed a fivefold increase but fetal iron content was not modified, suggesting that transfer of iron across the placenta is, to quote, a rate-liming step (Martin et al., 2004). Despite these evidences, we would not rule out the possibility that, in our model, excessive iron in the placenta is toxic for the fetus; the observation that iron accumulates at the interface with fetal capillaries and possibly in the fetal circulation allows us to speculate toward this direction.
FIGURE 4. Iron accumulation in trophoblasts. Placentas from Plasmodium-infected pregnant females were evaluated at G19 for iron accumulation by Prussian blue staining in placental sections. (A,B) Non-infected placenta showing maternal blood space (MBS) and fetal capillary (FC) separated by trophoblast. (C,D) Infected placenta from a live fetus that shows no iron accumulation in trophoblasts and fairly preserved tissue structure; (E,F) Infected placenta from a dead fetus showing significant iron accumulation (blue) in trophoblast and loss of integrity of the tissue structure. Iron seems to be accumulated in phagocytic trophoblasts (surrounded area in F and box in G) and at the interface between trophoblast and fetal capillary (arrows in F) but not in MBS (E–G). Areas delimitated in A,C,E are magnified (crop and zoom) in B,D,F, respectively. Scale bars: 25 μm (A,C,E) and 10 μm (G). Arrowheads point to infected erythrocytes.
The mechanism proposed to explain iron accumulation in our model relies on dysregulation of intracellular heme homeostasis leading to iron overload presumably occurring as a consequence of increased IE phagocytosis by trophoblasts. These cells are capable of engulfing and digesting red blood cells (Albieri and Bevilacqua, 1996) possibly for fetal nutrition at the beginning of gestation (Bevilacqua and Abrahamsohn, 1989); hence, it is possible that the mechanisms involved in iron recycling from Hb in the trophoblast occurs as in macrophages (Bratosin et al., 1998). We would expect that following phagocytosis, disrupted erythrocytes would lead to intracellular accumulation of cell-free Hb, a tetramer responsible for oxygen transport (Bratosin et al., 1998) which upon oxidation releases its heme prosthetic groups (Schechter, 2008). Non-Hb bound heme (free heme) sensitizes non-hematopoietic cells to undergo programmed cell death in response to pro-inflammatory agonists such as tumor necrosis factor (TNF) released in the course of the infection (Seixas et al., 2009). This deleterious effect is caused by the iron atom contained within the protoporphyrin ring of the heme molecule and its ability to produce highly reactive hydroxyl radicals via its participation in the Fenton chemistry (Gozzelino et al., 2012).
Degradation of heme by the heme catabolizing enzyme heme oxygenase 1 (HO-1) prevents heme-induced iron cytotoxicity and generates equimolar amounts of labile iron (Fe2+), carbon monoxide (CO), and biliverdin (Tenhunen et al., 1968; Choi and Alam, 1996; Soares and Bach, 2009; Gozzelino et al., 2010). Expression of HO-1 is induced in a variety of stress responses, including to heme itself and is encoded by HMOX1 gene (Tenhunen et al., 1968). This is achieved by suppressing the activity of Bach-1, transcriptional repressor of Hmox-1 gene (Sun et al., 2002; Gozzelino et al., 2010). The crucial role of HO-1 has already been demonstrated in cerebral and severe forms of malaria (Pamplona et al., 2007; Seixas et al., 2009; Ferreira et al., 2011); increased expression of this detoxifying enzyme strongly correlates with the ability to survive the infection. The protection afforded by HO-1 relies on the inhibition of heme sensitization to programmed cell death.
To limit pro-oxidant effects of iron, a regulatory mechanism evolved to couple heme catabolism and maintenance of iron homeostasis. This metabolic iron adaptation is conferred by the expression of ferritin heavy/heart chain (FtH; Gozzelino and Soares, 2014). Conversion of Fe2+ into inert Fe3+ is attributed to the ferroxidase activity of FtH, a property necessary to neutralize the redox activity of labile iron and prevent generation of oxidative stress (Eisenstein et al., 1991; Harrison and Arosio, 1996). This allows storage of iron inside the multimeric complex of ferritin, formed by 24 subunits of FtH and ferritin light/liver chain (FtL; Arosio and Levi, 2002) at proportions that varies between different tissues (Harrison and Arosio, 1996). The iron storage capacity of the multimeric complex of ferritin can incorporate up to 4500 iron atoms (Harrison and Arosio, 1996), as inorganic ferrihydrite aggregates from which are then released according to cellular requirements (Koorts and Viljoen, 2007). The mechanism of release is currently not understood.
The cytoprotective effect of FtH relies on its anti-oxidant properties, which reduce free radicals production (Balla et al., 1992). Reactive oxygen species (ROS) are responsible for sustained activation of JNK (Kamata et al., 2005) which induces caspase-3 cleavage and programmed cell death (Gozzelino et al., 2012). Through inhibition of ROS, FtH diminishes JNK phosphorylation (Pham et al., 2004) preventing cell death. In malaria infection, FtH was shown to prevent tissue damage and reduces disease severity by providing a metabolic adaptation to tissue iron overload; this enables mice and humans to survive to the infection (Gozzelino et al., 2012). Further experiments would be required in our PM model to assess the mechanisms by which FtH can protect against trophoblast damage.
Intracellular accumulation of free heme is also controlled by the expression of proteins that regulate heme trafficking inside the cells, known as heme transporters (Yuan et al., 2013). Extracellular release of excessive heme is mediated by the expression of membrane proteins that act as heme exporters, such as BCRP/ABCG2 (Krishnamurthy and Schuetz, 2005) and two isoforms of the FLVCR1 (Keel et al., 2008; Chiabrando et al., 2012). FLVCR1a is a cell surface molecule and regulates heme extracellular exit (Keel et al., 2008; Vinchi et al., 2014); FLVCR1b is a mitochondrial protein that controls heme efflux into the cytosol for hemoglobinization and erythroid differentiation (Chiabrando et al., 2012).
Our preliminary data also show that FLVCR1a mRNA expression in infected placentas is downregulated (data not shown) suggesting that reduced FLVCR1a expression together with intense trophoblast phagocytic activity may contribute to intracellular heme accumulation (Figure 5). Placenta has been shown to express high amounts of FLVCR1 (Jaacks et al., 2011) but the functional roles of this molecule in this tissue are poorly investigated. FLVCR1 is required for erythroid differentiation maintaining the balance of intracellular free heme during erythropoiesis (Quigley et al., 2004) and has an important role in iron recycling by macrophages (Keel et al., 2008). It has been suggested that expression of FLVCR1 in the placenta may reverse the flow of heme from this tissue to maternal circulation, so to prevent the fetoplacental unit from iron toxicity (Cao and O’Brien, 2013). Analysis of FLVCR1 expression in a population of pregnant adolescents at high risk of iron deficiency showed that FLVCR1 was downregulated in placentas of anemic mothers at term (Jaacks et al., 2011). In our PM model it is possible that placental FLVCR1a downregulation may be linked to maternal anemia induced by Plasmodium infection. Engulfing high numbers of sequestered IEs in low maternal blood flow regions by trophoblasts expressing low levels of FLVCR1a could result in heme accumulation. We have not yet determined if Hb levels and FLVCR1a expression correlates to IE expansion in the placenta, which could possibly explain iron overload in placentas from mice infected with higher parasite numbers.
FIGURE 5. Hypothesis explaining heme-iron overload in trophoblast according to IE load. Left panel: (A) increased phagocytosis of IEs and possibly non-IEs by cytotrophoblast (CTB) and syncythiotrophoblasts (STB) in low blood flow regions in maternal blood space (MBS) where IE and non-IE are sequestered; (B) disruption of erythrocytes in the phagocytic vacuole leads to free heme exposure; downregulation of FLVCR1a on trophoblasts might cause free heme accumulation due to decreased heme export; (C) heme catabolism by HO-1 generates large amounts of iron which may exceed ferritin binding capacity; (D) free iron (Fe2+) induces cell death by ROS. Right panel: (A) lower placental infection might not affect FLVCR1a expression and phagocytosis is decreased; (B) excessive free heme is exported from the cell; (C) iron from heme catabolism is neutralized by ferritin; and (D) trophoblasts are protected from programmed cell death.
We could argue that mechanisms involved in the putative heme-induced cellular damage observed in infected placentas could be associated with a decrease in expression of cytoprotective proteins, such as HO-1 and ferritin. These proteins cooperate to degrade heme and neutralize the iron released from the protoporphyrin ring of the heme molecule (Gozzelino and Soares, 2014). Whilst HO-1 is responsible for heme catabolism, expression of ferritin is crucial to neutralize iron generated through heme degradation and store it inside its multimeric structure (Gozzelino and Soares, 2014). This would lead to insufficient function to prevent the damage induced by intracellular heme accumulation. In fact, administration of anti-oxidant compounds that mimic the cytoprotective effect of HO-1 prevented heme-mediated cytotoxicity and pathological outcomes of Plasmodium infection in mice (Seixas et al., 2009). However, a recent study in mice with conditional disruption of Flvcr1a gene in the liver showed that in the absence of FLVCR1a heme and iron accumulated in this organ and that genes such as Ho-1, Fpn, H-Ft and L-Ft were upregulated suggesting that FLVCR1a is associated to heme degradation (Vinchi et al., 2014). Therefore it is possible that in our model heme degradation pathway in trophoblasts is upregulated to compensate for the impaired function of heme export by FLVCR1a, as previously suggested (Vinchi et al., 2014).
Heme is synthesized in the mitochondria by a series of enzymatic reactions and exported to the cytosol to be incorporated in hemoproteins (reviewed in Chiabrando et al., 2014). Mice lacking FLVCR1a in the liver also showed downregulation of genes involved in the heme biosynthesis after injection of heme precursor 5-aminolevulinic acid (ALA) whereas in controls treatment induced FLVCR1a upregulation (Vinchi et al., 2014). Extrapolation of this evidence to our model allow the speculation that free heme accumulation after intense phagocytosis of IEs by trophoblast could repress heme de novo biosynthesis which in turn downregulates FLVCR1a expression.
Whether there is a role for HO-1 in protection against PM remains to be established. The notion that this protein is essential for processes such as oocyte maturation, fertilization, fetus implantation, and acceptance, Bainbridge and Smith (2005) and Zenclussen et al. (2007) suggests that the positive potential of HO-1 in PM is worth to be tested.
Final Remarks
Our PM model represents a severe form of the disease; mechanisms underlying fetal death are still unclear. Our initial observation that only 43% of placentas from dead fetuses showed iron accumulation in trophoblasts (Table 1) suggests that iron overload in PM is a heterogeneous and progressive process and potentially represents one of the mechanisms to explain fetal demise. The amount of iron in the placenta was significantly associated with infection dose (Figure 2 and Table 2) implying that the higher the degree of infection the higher the probability of iron accumulation. Pregnancy outcomes are improved when mice are infected with IE doses 100× times lower than usual; incidence of fetal death is greatly decreased and birth weight is comparable to normal (unpublished) suggesting that here infection does not have an important impact on fetal development. It could also indicate that lower infection levels may not deprive the organism of the capacity to activate cytoprotective molecules controlling regulation of heme/iron homeostasis. This is further supported by the observation that iron accumulation in infected placentas is associated with the number of injected IEs.
The main hypothesis we formulate in this article is that increased phagocytosis of IEs by trophoblasts leads to intracellular iron overload as a consequence of accumulation of free heme after IE disruption. Based on preliminary evidences we suggest that infection induces downregulation of FLVCR1a which affects heme homeostasis triggering cytotoxic events in trophoblasts and impairing fetal development.
Whether Plasmodium infection induces dysregulation of molecules involved in heme-iron uptake, storage and/or efflux leading to intracellular iron overload is highly speculative. Nevertheless, our observations that iron was accumulated at the interface between trophoblast basal membrane and fetal capillary encourage the investigation of FPN expression levels in the infected placenta. We could further elaborate that insufficient function of FLVCR1a in exporting intracellular heme together with inefficient iron export through FPN (if shown to be downregulated) might both contribute to iron accumulation in trophoblasts. Our current observations warrant further efforts to investigate iron metabolism in PM.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors would like to thank the Histopathology Unit at Instituto Gulbenkian de Ciência for performing histological sections and Richard Hampson for proof reading the manuscript. This work was supported by fundings from Fundação de Ciência e Tecnologia (FCT), Portugal (EXPL-IMI-IMU-0428/2013). Raffaella Gozzelino and Luciana V. de Moraes are recipients of Post-Doctoral fellowships SFRH/BPD/44256/2008 and 44486/2008, respectively.
References
Abrams, E. T., Brown, H., Chensue, S. W., Turner, G. D., Tadesse, E., Lema, V. M.,et al. (2003). Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J. Immunol. 170, 2759–2764. doi: 10.4049/jimmunol.170.5.2759
Abrams, E. T., Kwiek, J. J., Mwapasa, V., Kamwendo, D. D., Tadesse, E.,Lema, V. M.,et al. (2005). Malaria during pregnancy and foetal haematological status in Blantyre, Malawi. Malar. J. 4, 39. doi: 10.1186/1475-2875-4-39
Adam, I., Ehassan, E. M., Mohmmed, A. A., Salih, M. M., and Elbashir, M. I. (2012). Decreased susceptibility to placental malaria in anaemic women in an area with unstable malaria transmission in central Sudan. Pathog. Glob. Health 106, 118–121. doi: 10.1179/2047773212Y.0000000011
Aisen, P. (1998). Transferrin, the transferrin receptor, and the uptake of iron by cells. Met. Ions Biol. Syst. 35, 585–631.
Albieri, A., and Bevilacqua, E. (1996). Induction of erythrophagocytic activity in cultured mouse trophoblast cells by phorbol myristate acetate and all-trans-retinal. Placenta 17, 507–512. doi: 10.1016/S0143-4004(96)90033-8
Amarante-Paffaro, A., Queiroz, G. S., Corrêa, S. T., Spira, B., and Bevilacqua, E. (2004). Phagocytosis as a potential mechanism for microbial defense of mouse placental trophoblast cells. Reproduction 128, 207–218. doi: 10.1530/rep.1.00214
Andrews, N. C. (1999). The iron transporter DMT1. Int. J. Biochem. Cell Biol. 31, 991–994. doi: 10.1016/S1357-2725(99)00065-65
Andrews, N. C. (2000). Iron homeostasis: insights from genetics and animal models. Nat. Rev. Genet. 1, 208–217. doi: 10.1038/35042073
Arosio, P., and Levi, S. (2002). Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33, 457–463. doi: 10.1016/S0891-5849(02)00842-0
Avery, J. W., Smith, G. M., Owino, S. O., Sarr, D., Nagy, T., Mwalimu, S.,et al. (2012). Maternal malaria induces a procoagulant and antifibrinolytic state that is embryotoxic but responsive to anticoagulant therapy. PLoS ONE 7:e31090. doi: 10.1371/journal.pone.0031090
Bainbridge, S. A., and Smith, G. N. (2005). HO in pregnancy. Free Radic. Biol. Med. 38, 979–988. doi: 10.1016/j.freeradbiomed.2004.11.002
Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F.,et al. (1992). Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 18148–18153.
Bastin, J., Drakesmith, H., Rees, M., Sargent, I., and Townsend, A. (2006). Localisation of proteins of iron metabolism in the human placenta and liver. Br. J. Haematol. 134, 532–543. doi: 10.1111/j.1365-2141.2006.06216.x
Bevilacqua, E. M., and Abrahamsohn, P. A. (1989). Trophoblast invasion during implantation of the mouse embryo. Arch. Biol. Med. Exp. 22, 107–118.
Bothwell, T. H. (2000). Iron requirements in pregnancy and strategies to meet them. Am. J. Clin. Nutr. 72, 257S–264S.
Bratosin, D., Mazurier, J., Tissier, J. P., Estaquier, J., Huart, J. J., Ameisen, J. C.,et al. (1998). Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80, 173–195. doi: 10.1016/S0300-9084(98)80024-2
Cabantchik, Z. I., Glickstein, H., Golenser, J., Loyevsky, M., and Tsafack, A. (1996). Iron chelators: mode of action as antimalarials. Acta Haematol. 95, 70–77. doi: 10.1159/000203952
Cao, C., and O’Brien, K. O. (2013). Pregnancy and iron homeostasis: an update. Nutr. Rev. 71, 35–51. doi: 10.1111/j.1753-4887.2012.00550.x
Carter, J. A., Mung’ala-Odera, V., Neville, B. G. R., Murira, G., Mturi, N., Musumba, C.,et al. (2005). Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J. Neurol. Neurosurg. Psychiatr. 76, 476–481. doi: 10.1136/jnnp.2004.043893
Chiabrando, D., Marro, S., Mercurio, S., Giorgi, C., Petrillo, S., Vinchi, F.,et al. (2012). The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. J. Clin. Invest. 122, 4569–4579. doi: 10.1172/JCI62422
Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., and Tolosano, E. (2014). Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front. Pharmacol. 5:61. doi: 10.3389/fphar.2014.00061
Choi, A. M., and Alam, J. (1996). Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15, 9–19. doi: 10.1165/ajrcmb.15.1.8679227
Cornock, R., Gambling, L., Langley-Evans, S. C., McArdle, H. J., and McMullen, S. (2013). The effect of feeding a low iron diet prior to and during gestation on fetal and maternal iron homeostasis in two strains of rat. Reprod. Biol. Endocrinol. 11, 32. doi: 10.1186/1477-7827-11-32
Crichton, R. R., and Charloteaux-Wauters, M. (1987). Iron transport and storage. Eur. J. Biochem. 164, 485–506. doi: 10.1111/j.1432-1033.1987.tb11155.x
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., and ter Kuile, F. O. (2010). Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 7:e1000221. doi: 10.1371/journal.pmed.1000221
de Moraes, L. V., Tadokoro, C. E., Gómez-Conde, I., Olivieri, D. N., and Penha-Gonçalves, C. (2013). Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of Plasmodium-infected erythrocytes. PLoS Pathog. 9:e1003154. doi: 10.1371/journal.ppat.1003154
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J.,et al. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781. doi: 10.1038/35001596
Duffy, M. F., Maier, A. G., Byrne, T. J., Marty, A. J., Elliott, S. R., O’Neill, M. T.,et al. (2006). VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 148, 117–124. doi: 10.1016/j.molbiopara.2006.03.006
Duffy, P. E., and Fried, M. (1999). Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A. Biochem. Soc. Trans. 27, 478–482.
Eisenstein, R. S., Garcia-Mayol, D., Pettingell, W., and Munro, H. N. (1991). Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc. Natl. Acad. Sci. U.S.A. 88, 688–692. doi: 10.1073/pnas.88.3.688
Endo, H., Okamoto, A., Yamada, K., Nikaido, T., and Tanaka, T. (2005). Frequent apoptosis in placental villi from pregnancies complicated with intrauterine growth restriction and without maternal symptoms. Int. J. Mol. Med. 16, 79–84. doi: 10.3892/ijmm.16.1.79
Feelders, R. A., Kuiper-Kramer, E. P., and van Eijk, H. G. (1999). Structure, function and clinical significance of transferrin receptors. Clin. Chem. Lab. Med. 37, 1–10. doi: 10.1515/CCLM.1999.001
Fenton, H. (1894). Oxidation of tartaric acid in presence of iron. J. Chem. Soc. (Lond.) 65, 899–910. doi: 10.1039/ct8946500899
Ferreira, A., Marguti, I., Bechmann, I., Jeney, V., Chora, A., Palha, N. R.,et al. (2011). Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 145, 398–409. doi: 10.1016/j.cell.2011.03.049
Fleming, M. D., Trenor, C. C. III, Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F.,et al. (1997). Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16, 383–386. doi: 10.1038/ng0897-383
Fonager, J., Pasini, E. M., Braks, J. A. M., Klop, O., Ramesar, J., Remarque, E. J.,et al. (2012). Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo. J. Exp. Med. 209, 93–107. doi: 10.1084/jem.20110762
Fried, M., and Duffy, P. E. (1996). Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272, 1502–1504. doi: 10.1126/science.272.5267.1502
Friedman, J. F., Kurtis, J. D., Kabyemela, E. R., Fried, M., and Duffy, P. E. (2009). The iron trap: iron, malaria and anemia at the mother-child interface. Microbes Infect. 11, 460–466. doi: 10.1016/j.micinf.2009.02.006
Gambling, L., Czopek, A., Andersen, H. S., Holtrop, G., Srai, S. K. S., Krejpcio, Z.,et al. (2009). Fetal iron status regulates maternal iron metabolism during pregnancy in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R1063–R1070. doi: 10.1152/ajpregu.90793.2008
Gambling, L., Danzeisen, R., Gair, S., Lea, R. G., Charania, Z., Solanky, N.,et al. (2001). Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. Biochem. J. 356, 883–889. doi: 10.1042/0264-6021:3560883
Ganz, T. (2009). Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21, 63–67. doi: 10.1016/j.coi.2009.01.011
Georgieff, M. K., Wobken, J. K., Welle, J., Burdo, J. R., and Connor, J. R. (2000). Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta 21, 799–804. doi: 10.1053/plac.2000.0566
Gozzelino, R., Andrade, B. B., Larsen, R., Luz, N. F., Vanoaica, L., Seixas, E.,et al. (2012). Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12, 693–704. doi: 10.1016/j.chom.2012.10.011
Gozzelino, R., Jeney, V., and Soares, M. P. (2010). Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50, 323–354. doi: 10.1146/annurev.pharmtox.010909.105600
Gozzelino, R., and Soares, M. P. (2014). Coupling heme and iron metabolism via ferritin H chain. Antioxid. Redox Signal. 20, 1754–1769. doi: 10.1089/ars.2013.5666
Griesinger, G., Saleh, L., Bauer, S., Husslein, P., and Knöfler, M. (2001). Production of pro- and anti-inflammatory cytokines of human placental trophoblasts in response to pathogenic bacteria. J. Soc. Gynecol. Investig. 8, 334–340. doi: 10.1016/S1071-5576(01)00135-6
Gruper, Y., Bar, J., Bacharach, E., and Ehrlich, R. (2005). Transferrin receptor co-localizes and interacts with the hemochromatosis factor (HFE) and the divalent metal transporter-1 (DMT1) in trophoblast cells. J. Cell. Physiol. 204, 901–912. doi: 10.1002/jcp.20349
Guidotti, R. J. (2000). Anaemia in pregnancy in developing countries. Br. J. Obstet. Gynaecol. 107, 437–438. doi: 10.1111/j.1471-0528.2000.tb13258.x
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F.,et al. (1997). Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482–488. doi: 10.1038/41343
Haldar, K., Murphy, S. C., Milner, D. A., and Taylor, T. E. (2007). Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu. Rev. Pathol. 2, 217–249. doi: 10.1146/annurev.pathol.2.010506.091913
Harrison, P. M., and Arosio, P. (1996). The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161–203. doi: 10.1016/0005-2728(96)00022-9
Hentze, M. W., Muckenthaler, M. U., and Andrews, N. C. (2004). Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285–297. doi: 10.1016/S0092-8674(04)00343-5
Jaacks, L. M., Young, M. F., Essley, B. V., McNanley, T. J., Cooper, E. M., Pressman, E. K.,et al. (2011). Placental expression of the heme transporter, feline leukemia virus subgroup C receptor, is related to maternal iron status in pregnant adolescents. J. Nutr. 141, 1267–1272. doi: 10.3945/jn.110.135798
Janicik, J. M., Schauer, R., Andres, K. H., and von Düring, M. (1978). Sequestration of neuraminidase-treated erythrocytes. Studies on its topographic, morphologic and immunologic aspects. Cell Tissue Res. 186, 209–226.
Jemmely, N. Y., Niang, M., and Preiser, P. R. (2010). Small variant surface antigens and Plasmodium evasion of immunity. Future Microbiol. 5, 663–682. doi: 10.2217/fmb.10.21
Kabyemela, E. R., Fried, M., Kurtis, J. D., Mutabingwa, T. K., and Duffy, P. E. (2008). Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J. Infect. Dis. 198, 163–166. doi: 10.1086/589512
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005). Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649–661. doi: 10.1016/j.cell.2004.12.041
Kane, E. G., and Taylor-Robinson, A. W. (2011). Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites. Malar. Res. Treat. 2011, 764845. doi: 10.4061/2011/764845
Keel, S. B., Doty, R. T., Yang, Z., Quigley, J. G., Chen, J., Knoblaugh, S.,et al. (2008). A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 319, 825–828. doi: 10.1126/science.1151133
Koorts, A. M., and Viljoen, M. (2007). Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch. Physiol. Biochem. 113, 30–54. doi: 10.1080/13813450701318583
Krishnamurthy, P., and Schuetz, J. D. (2005). The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 18, 349–358. doi: 10.1007/s10534-005-3709-7
Kroos, M. J., Starreveld, J. S., Verrijt, C. E., van Eijk, H. G., and van Dijk, J. P. (1996). Regulation of transferrin receptor synthesis by human cytotrophoblast cells in culture. Eur. J. Obstet. Gynecol. Reprod. Biol. 65, 231–234. doi: 10.1016/0301-2115(95)02368-2
Krücken, J., Mehnert, L. I., Dkhil, M. A., El-Khadragy, M., Benten, W. P. M., Mossmann, H.,et al. (2005). Massive destruction of malaria-parasitized red blood cells despite spleen closure. Infect. Immun. 73, 6390–6398. doi: 10.1128/IAI.73.10.6390-6398.2005
Levy, A., Fraser, D., Katz, M., Mazor, M., and Sheiner, E. (2005). Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 182–186. doi: 10.1016/j.ejogrb.2005.02.015
Li, Y.-Q., Bai, B., Cao, X.-X., Yan, H., and Zhuang, G.-H. (2012a). Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment. Cell Biochem. Funct. 30, 249–255. doi: 10.1002/cbf.1843
Li, Y.-Q., Bai, B., Cao, X.-X., Zhang, Y.-H., Yan, H., Zheng, Q.-Q.,et al. (2012b). Divalent metal transporter 1 expression and regulation in human placenta. Biol. Trace Elem. Res. 146, 6–12. doi: 10.1007/s12011-011-9214-7
Li, Y.-Q., Yan, H., and Bai, B. (2008). Change in iron transporter expression in human term placenta with different maternal iron status. Eur. J. Obstet. Gynecol. Reprod. Biol. 140, 48–54. doi: 10.1016/j.ejogrb.2008.02.012
Lucchi, N. W., Peterson, D. S., and Moore, J. M. (2008). Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum. Malar. J. 7, 42. doi: 10.1186/1475-2875-7-42
Lucchi, N. W., Sarr, D., Owino, S. O., Mwalimu, S. M., Peterson, D. S., and Moore, J. M. (2011). Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells. Placenta 32, 579–585. doi: 10.1016/j.placenta.2011.05.003
Mackintosh, C. L., Beeson, J. G., and Marsh, K. (2004). Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20, 597–603. doi: 10.1016/j.pt.2004.09.006
Martin, M. E., Nicolas, G., Hetet, G., Vaulont, S., Grandchamp, B., and Beaumont, C. (2004). Transferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos. FEBS Lett. 574, 187–191. doi: 10.1016/j.febslet.2004.08.010
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D.,et al. (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5, 299–309. doi: 10.1016/S1097-2765(00)80425-6
Menendez, C., Todd, J., Alonso, P. L., Francis, N., Lulat, S., Ceesay, S.,et al. (1994). The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans. R. Soc. Trop. Med. Hyg. 88, 590–593. doi: 10.1016/0035-9203(94)90176-7
Milman, N. (2006). Iron and pregnancy – a delicate balance. Ann. Hematol. 85, 559–565. doi: 10.1007/s00277-006-0108-2
Mokuolu, O. A., Falade, C. O., Orogade, A. A., Okafor, H. U., Adedoyin, O. T., Oguonu, T. A.,et al. (2009). Malaria at parturition in Nigeria: current status and delivery outcome. Infect. Dis. Obstet. Gynecol. 2009, 473971. doi: 10.1155/2009/473971
Mu, J., Kanzaki, T., Si, X., Tomimatsu, T., Fukuda, H., Shioji, M.,et al. (2003). Apoptosis and related proteins in placenta of intrauterine fetal death in prostaglandin f receptor-deficient mice. Biol. Reprod. 68, 1968–1974. doi: 10.1095/biolreprod.102.008029
Murray, M. J., and Stein, N. (1970). The contribution of maternal iron stores to fetal iron in rats. J. Nutr. 100, 1023–1025.
Nacher, M., McGready, R., Stepniewska, K., Cho, T., Looareesuwan, S., White, N. J.,et al. (2003). Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 97, 273–276. doi: 10.1016/S0035-9203(03)90140-4
Nakashima, A., Shiozaki, A., Myojo, S., Ito, M., Tatematsu, M., Sakai, M.,et al. (2008). Granulysin produced by uterine natural killer cells induces apoptosis of extravillous trophoblasts in spontaneous abortion. Am. J. Pathol. 173, 653–664. doi: 10.2353/ajpath.2008.071169
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M.,et al. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093. doi: 10.1126/science.1104742
Neres, R., Marinho, C. R., Goncalves, L. A., Catarino, M. B., and Penha-Goncalves, C. (2008). Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS ONE 3:e1608. doi: 10.1371/journal.pone.0001608
Okoko, B. J., Enwere, G., and Ota, M. O. C. (2003). The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop. 87, 193–205. doi: 10.1016/S0001-706X(03)00097-4
Olivares, E. G., Muñoz, R., Tejerizo, G., Montes, M. J., Gómez-Molina, F., and Abadía-Molina, A. C. (2002). Decidual lymphocytes of human spontaneous abortions induce apoptosis but not necrosis in JEG-3 extravillous trophoblast cells. Biol. Reprod. 67, 1211–1217. doi: 10.1095/biolreprod67.4.1211
Oppenheimer, S. J., Macfarlane, S. B., Moody, J. B., and Harrison, C. (1986). Total dose iron infusion, malaria and pregnancy in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 80, 818–822. doi: 10.1016/0035-9203(86)90393-7
Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S.,et al. (2007). Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13, 703–710. doi: 10.1038/nm1586
Pavia, C. S., and Niederbuhl, C. J. (1991). Immunization and protection against malaria during murine pregnancy. Am. J. Trop. Med. Hyg. 44, 176–182.
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K.,et al. (2004). Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119, 529–542. doi: 10.1016/j.cell.2004.10.017
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A.,et al. (2008). Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin. Infect. Dis. 46, 1374–1381. doi: 10.1086/586743
Pongponratn, E., Riganti, M., Punpoowong, B., and Aikawa, M. (1991). Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 44, 168–175.
Ponsford, M. J., Medana, I. M., Prapansilp, P., Hien, T. T., Lee, S. J., Dondorp, A. M.,et al. (2012). Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J. Infect. Dis. 205, 663–671. doi: 10.1093/infdis/jir812
Poovassery, J., and Moore, J. M. (2009). Association of malaria-induced murine pregnancy failure with robust peripheral and placental cytokine responses. Infect. Immun. 77, 4998–5006. doi: 10.1128/IAI.00617-09
Poovassery, J. S., Sarr, D., Smith, G., Nagy, T., and Moore, J. M. (2009). Malaria-induced murine pregnancy failure: distinct roles for IFN-γ and TNF. J. Immunol. 183, 5342–5349. doi: 10.4049/jimmunol.0901669
Punnonen, K., Irjala, K., and Rajamäki, A. (1997). Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89, 1052–1057.
Quigley, J. G., Yang, Z., Worthington, M. T., Phillips, J. D., Sabo, K. M., Sabath, D. E.,et al. (2004). Identification of a human heme exporter that is essential for erythropoiesis. Cell 118, 757–766. doi: 10.1016/j.cell.2004.08.014
Rodrigues-Duarte, L., Vieira de Moraes, L., Barboza, R., Marinho, C. R., Franke-Fayard, B., Janse, C. J.,et al. (2012). Distinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57Bl/6 mouse. Malar. J. 11, 231. doi: 10.1186/1475-2875-11-231
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P.,et al. (2004). Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200, 1197–1203. doi: 10.1084/jem.20041579
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E.,et al. (2003). Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol. Microbiol. 49, 179–191. doi: 10.1046/j.1365-2958.2003.03570.x
Schechter, A. N. (2008). Hemoglobin research and the origins of molecular medicine. Blood 112, 3927–3938. doi: 10.1182/blood-2008-04-078188
Schofield, L., and Grau, G. E. (2005). Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5, 722–735. doi: 10.1038/nri1686
Seixas, E., Gozzelino, R., Chora, A., Ferreira, A., Silva, G., Larsen, R.,et al. (2009). Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. U.S.A. 106, 15837–15842. doi: 10.1073/pnas.0903419106
Senga, E. L., Harper, G., Koshy, G., Kazembe, P. N., and Brabin, B. J. (2011). Reduced risk for placental malaria in iron deficient women. Malar. J. 10, 47. doi: 10.1186/1475-2875-10-47
Sibley, C. P., Brownbill, P., Dilworth, M., and Glazier, J. D. (2010). Review: adaptation in placental nutrient supply to meet fetal growth demand: implications for programming. Placenta 31(Suppl.) S70–S74. doi: 10.1016/j.placenta.2009.12.020
Simavli, S., Derbent, A. U., Uysal, S., and Turhan, N.Ö. (2014). Hepcidin, iron status, and inflammation variables among healthy pregnant women in the Turkish population. J. Matern. Fetal Neonatal Med. 27, 75–79. doi: 10.3109/14767058.2013.804054
Soares, M. P., and Bach, F. H. (2009). Heme oxygenase-1: from biology to therapeutic potential. Trends Mol. Med. 15, 50–58. doi: 10.1016/j.molmed.2008.12.004
Srivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B.,et al. (2010). Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl. Acad. Sci. U.S.A. 107, 4884–4889. doi: 10.1073/pnas.1000951107
Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H.,et al. (2002). Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21, 5216–5224. doi: 10.1093/emboj/cdf516
Tachi, S., Tachi, C., and Lindner, H. R. (1970). Ultrastructural features of blastocyst attachment and trophoblastic invasion in the rat. J. Reprod. Fertil. 21, 37–56. doi: 10.1530/jrf.0.0210037
Tenhunen, R., Marver, H. S., and Schmid, R. (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61, 748–755. doi: 10.1073/pnas.61.2.748
Van Santen, S., de Mast, Q., Luty, A. J., Wiegerinck, E. T., Ven der Ven, A. J., and Swinkels, D. W. (2011). Iron homeostasis in mother and child during placental malaria infection. Am. J. Trop. Med. Hyg. 84, 148–151. doi: 10.4269/ajtmh.2011.10-0250
van Santen, S., Kroot, J. J. C., Zijderveld, G., Wiegerinck, E. T., Spaanderman, M. E. A., and Swinkels, D. W. (2013). The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study. Clin. Chem. Lab. Med. 51, 1395–1401. doi: 10.1515/cclm-2012-0576
Veuthy, T., and Wessling-Resnick, M. (2014). Pathophysiology of the Belgrade rat. Front. Pharmacol. 5:82. doi: 10.3389/fphar.2014.00082
Vinchi, F., Ingoglia, G., Chiabrando, D., Mercurio, S., Turco, E., Silengo, L.,et al. (2014). Heme exporter FLVCR1a regulates heme synthesis and degradation and controls activity of cytochromes P450. Gastroenterology 146, 1325–1338. doi: 10.1053/j.gastro.2014.01.053
WHO |World Malaria Report. (2013). WHO. Available at: http://www.who.int/malaria/publications/world_malaria_report_2013/report/en (accessed April 15, 2014).
Yuan, X., Fleming, M. D., and Hamza, I. (2013). Heme transport and erythropoiesis. Curr. Opin. Chem. Biol. 17, 204–211. doi: 10.1016/j.cbpa.2013.01.010
Keywords: pregnancy malaria, heme, iron, fetal death, trophoblast
Citation: Penha-Gonçalves C, Gozzelino R and de Moraes LV (2014) Iron overload in Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death. Front. Pharmacol. 5:155. doi: 10.3389/fphar.2014.00155
Received: 02 May 2014; Accepted: 12 June 2014;
Published online: 01 July 2014.
Edited by:
Paolo Arosio, University of Brescia, ItalyReviewed by:
Francesca Vinchi, Heidelberg University, GermanyDemba Sarr, University of Georgia, USA
Copyright © 2014 Penha-Gonçalves, Gozzelino and de Moraes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Luciana V. de Moraes, Instituto Gulbenkian de Ciência, Rua da Quinta Grande 6, 2780-156 Oeiras, Portugal e-mail: lmoraes@igc.gulbenkian.pt